Vectura has an innovative and broad clinical pipeline that combines mid- and late-stage programmes with earlier-stage opportunities, addressing large and fast-growing market sectors, as well as a portfolio of revenue generating, marketed products.
Vectura has proprietary inhalation device and formulation technologies, which it uses to develop products in-house and with its pharmaceutical company partners.
Please use this page to learn more about the inhaled pharmaceuticals that Vectura is developing and its proprietary technologies.
Product pipeline
Information about Vectura’s products in clinical development. More
Marketed products
Information about Vectura’s revenue-generating marketed products. More
Product development strategy
Information about how Vectura develops inhaled pharmaceuticals. More
Proprietary technologies
Information about Vectura’s proprietary device technologies. More
Intellectual property
Information about Vectura’s patents and how it obtains additional value from its IP. More
Publications
View our list of publications. More
Licensing and collaborationTo learn more about Vectura’s licensing strategy and collaboration opportunities. More